1. 2023
  2. Genome-wide analyses of platinum-induced ototoxicity in childhood cancer patients: Results of GO-CAT and United Kingdom MAGIC consortia

    Hurkmans, E. G. E., Klumpers, M. J., Dello Russo, C., de Witte, W., Guchelaar, H-J., Gelderblom, H., Cleton-Jansen, A-M., Vermeulen, S. H., Kaal, S., van der Graaf, W. T. A., Flucke, U., Gidding, C. E. M., Schreuder, H. W. B., de Bont, E. S. J. M., Caron, H. N., Gattuso, G., Schiavello, E., Terenziani, M., Massimino, M., McCowage, G., & 12 othersNagabushan, S., Limaye, A., Rose, V., Catchpoole, D., Jorgensen, A. L., Barton, C., Delaney, L., Hawcutt, D. B., Pirmohamed, M., Pizer, B., Coenen, M. J. H. & te Loo, D. M. W. M., 9 Jan 2023, In: Frontiers in pharmacology. 13, 980309.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma

    Eleveld, T. F., Vernooij, L., Schild, L., Koopmans, B., Alles, L. K., Ebus, M. E., Dandis, R., van Tinteren, H., Caron, H. N., Koster, J., van Noesel, M. M., Tytgat, G. A. M., Eising, S., Versteeg, R., Dolman, M. E. M. & Molenaar, J. J., 2023, In: Frontiers in oncology. 13, 1130034.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. 2022
  5. SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin

    Hurkmans, E. G. E., Koenderink, J. B., van den Heuvel, J. J. M. W., Versleijen-Jonkers, Y. M. H., Hillebrandt-Roeffen, M. H. S., Groothuismink, J. M., Vos, H. I., van der Graaf, W. T. A., Flucke, U., Muradjan, G., Schreuder, H. W. B., Hagleitner, M. M., Brunner, H. G., Gelderblom, H., Cleton-Jansen, A-M., Guchelaar, H-J., de Bont, E. S. J. M., Touw, D. J., Nijhoff, G. J., Kremer, L. C. M., & 10 othersCaron, H., Windsor, R., Patiño-García, A., González-Neira, A., Saletta, F., McCowage, G., Nagabushan, S., Catchpoole, D., te Loo, D. M. W. M. & Coenen, M. J. H., 9 Nov 2022, In: Frontiers in pharmacology. 13, 1042989.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Target actionability review to evaluate CDK4/6 as a therapeutic target in paediatric solid and brain tumours

    Schubert, N. A., Chen, C. Y., Rodríguez, A., Koster, J., Dowless, M., Pfister, S. M., Shields, D. J., Stancato, L. F., Vassal, G., Caron, H. N., van den Boogaard, M. L., Henssen, A. G. & Molenaar, J. J., 1 Jul 2022, In: European Journal of Cancer. 170, p. 196-208 13 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. Target Actionability Review: a systematic evaluation of replication stress as a therapeutic target for paediatric solid malignancies

    Keller, K. M., Krausert, S., Gopisetty, A., Luedtke, D., Koster, J., Schubert, N. A., Rodríguez, A., van Hooff, S. R., Stichel, D., Dolman, M. E. M., Vassal, G., Pfister, S. M., Caron, H. N., Stancato, L. F., Molenaar, J. J., Jäger, N. & Kool, M., 1 Feb 2022, In: European Journal of Cancer. 162, p. 107-117 11 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  8. 2021
  9. A global approach to long-term follow-up of targeted and immune-based therapy in childhood and adolescence

    ACCELERATE Long-Term Follow-Up Working Group, Jul 2021, In: Pediatric blood & cancer. 68, 7, e29047.

    Research output: Contribution to journalComment/Letter to the editorAcademic

  10. 2020
  11. Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group

    Ambros, I. M., Tonini, G-P., Pötschger, U., Gross, N., Mosseri, V. R., Beiske, K., Berbegall, A. P., Bénard, J., Bown, N., Caron, H., Combaret, V., Couturier, J., Defferrari, R., Delattre, O., Jeison, M., Kogner, P., Lunec, J., Marques, B., Martinsson, T., Mazzocco, K., & 23 othersNoguera, R., Schleiermacher, G., Valent, A., van Roy, N., Villamon, E., Janousek, D., Pribill, I., Glogova, E., Attiyeh, E. F., Hogarty, M. D., Monclair, T. F., Holmes, K., Valteau-Couanet, D., Castel, V., Tweddle, D. A., Park, J. R., Cohn, S., Ladenstein, R., Beck-Popovic, M., de Bernardi, B., Michon, J., Pearson, A. D. J. & Ambros, P. F., 1 Nov 2020, In: Journal of clinical oncology. 38, 31, p. 3685-3697 13 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  12. Systematic target actionability reviews of preclinical proof-of-concept papers to match targeted drugs to paediatric cancers

    Schubert, N. A., Lowery, C. D., Bergthold, G., Koster, J., Eleveld, T. F., Rodríguez, A., Jones, D. T. W., Vassal, G., Stancato, L. F., Pfister, S. M., Caron, H. N. & Molenaar, J. J., May 2020, In: European journal of cancer (Oxford, England. 130, p. 168-181 14 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  13. 2019
  14. Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease Panel

    van Wezel, E. M., van Zogchel, L. M. J., van Wijk, J., Timmerman, I., Vo, N-K., Zappeij-Kannegieter, L., deCarolis, B., Simon, T., van Noesel, M., Molenaar, J. J., van Groningen, T., Versteeg, R., Caron, H. N., van der Schoot, C. E., Koster, J., van Nes, J. & Tytgat, G., 3 Oct 2019, In: JCO Precision Oncology. 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  15. Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort

    Teepen, J. C., Kremer, L. C., van der Heiden-van der Loo, M., Tissing, W. J., van der Pal, H. J., van den Heuvel-Eibrink, M. M., Loonen, J. J., Louwerens, M., Versluys, B., van Dulmen-den Broeder, E., Visser, O., Maduro, J. H., van Leeuwen, F. E., Ronckers, C. M. & the DCOG-LATER Study Group, 2019, In: Cancer causes & control.

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 4 5 6 7 8 ...26 Next

ID: 46426